Table 1. The mRNA expression of Per2, p53, Cyclin D1, CDK1 and Cyclin B1 in groups I, II and III at 6 different time points over 24 h (means ± SD, n = 5).
Gene | Tissue | 4HALO | 8HALO | 12HALO | 16HALO | 20HALO | 24HALO | P-value |
---|---|---|---|---|---|---|---|---|
Per2 | I | 0.86 ± 0.06 | 0.77 ± 0.10 | 1.89 ± 0.14 | 2.80 ± 0.11 | 1.18 ± 0.09 | 1.54 ± 0.19 | 0.000 |
II | 0.73 ± 0.18 | 1.33 ± 0.10 | 1.33 ± 0.19 | 1.46 ± 0.24 | 1.12 ± 0.26 | 0.29 ± 0.18 | 0.000 | |
III | 0.35 ± 0.14 | 1.02 ± 0.13 | 1.13 ± 0.24 | 1.47 ± 0.24 | 1.49 ± 0.25 | 0.35 ± 0.07 | 0.000 | |
p53 | I | 1.09 ± 0.26 | 1.86 ± 0.27 | 2.64 ± 0.21 | 3.82 ± 0.61 | 4.44 ± 1.40 | 6.20 ± 1.59 | 0.000 |
II | 2.64 ± 0.63 | 2.06 ± 0.33 | 1.22 ± 0.28 | 2.15 ± 0.20 | 2.63 ± 0.62 | 2.94 ± 1.45 | 0.001 | |
III | 1.37 ± 0.14 | 0.84 ± 0.03 | 0.71 ± 0.10 | 1.63 ± 0.17 | 1.82 ± 0.69 | 1.40 ± 0.34 | 0.003 | |
Cyclin D1 | I | 0.86 ± 0.12 | 0.90 ± 0.12 | 1.28 ± 0.37 | 2.51 ± 0.03 | 1.80 ± 1.40 | 1.17 ± 0.40 | 0.000 |
II | 2.40 ± 0.14 | 1.44 ± 0.29 | 1.36 ± 0.15 | 1.76 ± 0.16 | 2.14 ± 0.19 | 1.67 ± 0.09 | 0.000 | |
III | 2.38 ± 0.11 | 2.20 ± 0.08 | 2.90 ± 0.16 | 3.19 ± 0.10 | 2.64 ± 0.26 | 2.83 ± 0.24 | 0.000 | |
CDK1 | I | 5.91 ± 0.95 | 5.10 ± 0.45 | 1.70 ± 0.51 | 2.40 ± 0.44 | 1.21 ± 0.33 | 1.69 ± 0.32 | 0.000 |
II | 5.39 ± 0.55 | 6.55 ± 0.36 | 1.33 ± 0.11 | 2.08 ± 0.54 | 1.68 ± 0.28 | 10.0 ± 0.82 | 0.000 | |
III | 2.92 ± 0.49 | 1.68 ± 0.18 | 3.74 ± 0.36 | 6.69 ± 0.48 | 6.36 ± 0.61 | 7.24 ± 0.87 | 0.011 | |
Cyclin B1 | I | 1.16 ± 0.29 | 1.84 ± 0.12 | 0.39 ± 0.14 | 0.61 ± 0.23 | 1.06 ± 0.10 | 3.00 ± 0.37 | 0.000 |
II | 1.68 ± 0.27 | 1.92 ± 0.72 | 1.51 ± 0.72w | 2.00 ± 0.25 | 1.70 ± 0.25 | 1.94 ± 0.75 | 0.53 | |
III | 2.16 ± 0.64 | 1.79 ± 0.15 | 2.14 ± 0.16 | 2.48 ± 0.78 | 4.21 ± 1.00 | 2.55 ± 0.79 | 0.011 |
A value of P < 0.05 represents a significant difference ( I: normal buccal mucosa, II: precancerous lesion, and III: carcinoma; HALO: hour after light onset; SD: standard deviation; n: numbers).